MedPath

Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Major Abdominal Surgery

Phase 3
Completed
Conditions
Venous Thromboembolism
Interventions
Registration Number
NCT00679588
Lead Sponsor
Sanofi
Brief Summary

The primary objective is to compare the efficacy and safety of once daily (q.d.) subcutaneous (s.c.) injections of Semuloparin sodium (AVE5026) with q.d. s.c. injections of Enoxaparin for the prevention of Venous Thromboembolic Events (VTE) in patients undergoing major abdominal surgery.

The secondary objectives are to evaluate the safety of Semuloparin sodium (AVE5026) and to document Semuloparin sodium (AVE5026) exposure in this population.

Detailed Description

Randomization has to take place prior to the surgery.

The total duration of observation per participant is 35-42 days from surgery broken down as follows:

* 7 to 10-day double-blind treatment period;

* 28 to 35-day follow-up period.

Mandatory bilateral venography of the lower limbs has to be performed between 7 to 11 days after surgery.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
4413
Inclusion Criteria
  • Patient undergoing major abdominal surgery (open surgery under general anesthesia lasting more than 45 minutes in the peritoneal and/or retroperitoneal space and/or pelvis).

  • Patient <60 years of age had to have one of the following additional risk factors for VTE:

    • History of VTE,
    • Obesity,
    • Chronic Heart failure,
    • Chronic Respiratory Failure,
    • Inflammatory Bowel Disease,
    • Cancer Surgery.
Exclusion Criteria
  • Any major orthopedic or general surgery in the 3 months prior to study start;
  • Clinical signs or symptoms of DVT or PE within the last 12 months or known post phlebitic syndrome;
  • Any contra-indications to the performance of venography;
  • High risk of bleeding;
  • Known hypersensitivity to heparin or Enoxaparin sodium;
  • End stage renal disease or patient on dialysis.

The above information was not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
SemuloparinSemuloparin SodiumSemuloparin sodium 20 mg (10 mg if Severe Renal Impairment \[SRI\]) once daily for 7-10 days with an initial dose given 8 hours after surgery (placebo for Enoxaparin sodium prior to surgery according to local standard for Enoxaparin and 12 hours after surgery to maintain the blind)
SemuloparinPlaceboSemuloparin sodium 20 mg (10 mg if Severe Renal Impairment \[SRI\]) once daily for 7-10 days with an initial dose given 8 hours after surgery (placebo for Enoxaparin sodium prior to surgery according to local standard for Enoxaparin and 12 hours after surgery to maintain the blind)
EnoxaparinEnoxaparin sodiumEnoxaparin sodium 40 mg (20 mg if Severe Renal Impairment \[SRI\]) once daily for 7-10 days with an initial dose given prior to or 12 hours after surgery according to local standard for Enoxaparin sodium (placebo for Semuloparin sodium 8 hours after surgery to maintain the blind)
EnoxaparinPlaceboEnoxaparin sodium 40 mg (20 mg if Severe Renal Impairment \[SRI\]) once daily for 7-10 days with an initial dose given prior to or 12 hours after surgery according to local standard for Enoxaparin sodium (placebo for Semuloparin sodium 8 hours after surgery to maintain the blind)
Primary Outcome Measures
NameTimeMethod
Percentage of Participants Who Experience Venous Thromboembolism Event (VTE) or All-cause DeathFrom randomization up to 10 days after surgery or the day of mandatory venography, whichever comes first

VTE includes any proximal or distal Deep Vein Thrombosis (DVT) (symptomatic or not) and non-fatal Pulmonary Embolism (PE) as confirmed by a Central Independent Adjudication Committee (CIAC) after review of mandatory bilateral venograms and diagnostic tests for VTE.

All-cause deaths includes fatal PE and deaths for other reason than PE.

Secondary Outcome Measures
NameTimeMethod
Percentage of Participants Who Experience "major" VTE or All-cause DeathFrom randomization up to 10 days after surgery or the day of mandatory venography, whichever comes first

"major" VTE includes any proximal DVT, symptomatic distal DVT and non-fatal Pulmonary Embolism (PE) as as confirmed by the CIAC.

Percentage of Participants Who Experience Clinically Relevant Bleedings ("major" and "clinically relevant non-major" bleedings )From 1st study drug injection up to 3 days after last study drug injection

Bleedings are centrally and blindly reviewed by the CIAC and classified as:

* "major" (fatal, in a critical area/organ, causing a post-operative drop in hemoglobin ≥2 g/dL or requiring post-operative transfusion ≥2 units of blood, leading to an invasive diagnostic or therapeutic intervention, or associated with circulatory decompensation);

* "clinically relevant non-major" (skin hematoma or epistaxis requiring surgical/medical intervention/treatment, macroscopic hematuria, or overt bleeding requiring specific attention by health care professional);

* "Nonclinically relevant bleeding".

Percentage of Participants requiring the initiation of curative anticoagulant or thrombolytic treatment after VTE assessmentFrom randomization up to 10 days after surgery or the day of mandatory venography, whichever comes first

Initiation of curative anticoagulant or thrombolytic treatment after VTE assessment was defined from investigator's answer to the question "was the subject treated for VTE?" asked after the diagnostic tests for suspected VTE and after the mandatory venography.

Trial Locations

Locations (270)

Investigational Site Number 840036

🇺🇸

Springfield, Illinois, United States

Investigational Site Number 840007

🇺🇸

Huntingdon Beach, California, United States

Investigational Site Number 840017

🇺🇸

Jacksonville, Florida, United States

Investigational Site Number 840009

🇺🇸

Columbus, Georgia, United States

Investigational Site Number 032001

🇦🇷

Buenos Aires, Argentina

Investigational Site Number 032008

🇦🇷

Capital Federal, Argentina

Investigational Site Number 840031

🇺🇸

Corlton, California, United States

Investigational Site Number 356004

🇮🇳

Ahmedabad, India

Investigational Site Number 356006

🇮🇳

Coimbatore, India

Investigational Site Number 642003

🇷🇴

Cluj-Napoca, Romania

Investigational Site Number 710001

🇿🇦

Cape Town, South Africa

Investigational Site Number 642002

🇷🇴

Timisoara, Romania

Investigational Site Number 643019

🇷🇺

Krasnodar, Russian Federation

Investigational Site Number 643015

🇷🇺

Sestroretsk,, Russian Federation

Investigational Site Number 710003

🇿🇦

Worcester, South Africa

Investigational Site Number 752002

🇸🇪

Kungälv, Sweden

Investigational Site Number 792003

🇹🇷

Istanbul, Turkey

Investigational Site Number 642005

🇷🇴

Cluj-Napoca, Romania

Investigational Site Number 643026

🇷🇺

Omsk, Russian Federation

Investigational Site Number 724002

🇪🇸

Madrid, Spain

Investigational Site Number 642001

🇷🇴

Oradea, Romania

Investigational Site Number 643006

🇷🇺

Krasnoyarsk, Russian Federation

Investigational Site Number 752003

🇸🇪

Varberg, Sweden

Investigational Site Number 643007

🇷🇺

Novosibirsk, Russian Federation

Investigational Site Number 643010

🇷🇺

St. Petersburg, Russian Federation

Investigational Site Number 643009

🇷🇺

St.-Petersburg, Russian Federation

Investigational Site Number 792006

🇹🇷

Istanbul, Turkey

Investigational Site Number 688002

🇷🇸

Novi Sad, Serbia

Investigational Site Number 705001

🇸🇮

Celje, Slovenia

Investigational Site Number 792001

🇹🇷

Istanbul, Turkey

Investigational Site Number 724001

🇪🇸

Barcelona, Spain

Investigational Site Number 710004

🇿🇦

Cape Town, South Africa

Investigational Site Number 804010

🇺🇦

Donetsk, Ukraine

Investigational Site Number 826001

🇬🇧

London, United Kingdom

Investigational Site Number 156008

🇨🇳

Qingdao, China

Investigational Site Number 156014

🇨🇳

Tianjin, China

Investigational Site Number 112001

🇧🇾

Gomel, Belarus

Investigational Site Number 152002

🇨🇱

Rancagua, Chile

Investigational Site Number 203015

🇨🇿

Kolin, Czech Republic

Investigational Site Number 233003

🇪🇪

Tallinn, Estonia

Investigational Site Number 356027

🇮🇳

Bangalore, India

Investigational Site Number 356001

🇮🇳

Mangalore, India

Investigational Site Number 616003

🇵🇱

Bydgoszcz, Poland

Investigational Site Number 616011

🇵🇱

Torun, Poland

Investigational Site Number 604006

🇵🇪

Lima, Peru

Investigational Site Number 616010

🇵🇱

Lublin, Poland

Investigational Site Number 616008

🇵🇱

Wroclaw, Poland

Investigational Site Number 642006

🇷🇴

Cluj-Napoca, Romania

Investigational Site Number 643008

🇷🇺

Novosibirsk, Russian Federation

Investigational Site Number 643016

🇷🇺

Vsevolozhsk, Russian Federation

Investigational Site Number 643020

🇷🇺

Moscow, Russian Federation

Investigational Site Number 643021

🇷🇺

Moscow, Russian Federation

Investigational Site Number 643018

🇷🇺

St-Petersburg, Russian Federation

Investigational Site Number 688001

🇷🇸

Belgrade, Serbia

Investigational Site Number 643012

🇷🇺

Tomsk, Russian Federation

Investigational Site Number 688004

🇷🇸

Belgrade, Serbia

Investigational Site Number 703001

🇸🇰

Bratislava, Slovakia

Investigational Site Number 705002

🇸🇮

Maribor, Slovenia

Investigational Site Number 804003

🇺🇦

Cherkasy, Ukraine

Investigational Site Number 804007

🇺🇦

Donetsk, Ukraine

Investigational Site Number 804011

🇺🇦

Kharkiv, Ukraine

Investigational Site Number 804004

🇺🇦

Kyiv, Ukraine

Investigational Site Number 752004

🇸🇪

Norrköping, Sweden

Investigational Site Number 792007

🇹🇷

Izmir, Turkey

Investigational Site Number 076007

🇧🇷

Porto Alegre, Brazil

Investigational Site Number 124010

🇨🇦

Montreal, Canada

Investigational Site Number 124009

🇨🇦

Saint John, Canada

Investigational Site Number 124002

🇨🇦

Thunder Bay, Canada

Investigational Site Number 124007

🇨🇦

Vancouver, Canada

Investigational Site Number 276018

🇩🇪

Castrop-Rauxel, Germany

Investigational Site Number 276006

🇩🇪

Dresden, Germany

Investigational Site Number 840026

🇺🇸

Birmingham, Alabama, United States

Investigational Site Number 840035

🇺🇸

Birmingham, Alabama, United States

Investigational Site Number 840042

🇺🇸

Birmingham, Alabama, United States

Investigational Site Number 840002

🇺🇸

Birmingham, Alabama, United States

Investigational Site Number 840014

🇺🇸

Los Angeles, California, United States

Investigational Site Number 840021

🇺🇸

Denver, Colorado, United States

Investigational Site Number 840029

🇺🇸

Clearwater, Florida, United States

Investigational Site Number 840044

🇺🇸

Miami, Florida, United States

Investigational Site Number 840051

🇺🇸

Columbus, Ohio, United States

Investigational Site Number 840025

🇺🇸

Houston, Texas, United States

Investigational Site Number 840006

🇺🇸

Pittsburgh, Pennsylvania, United States

Investigational Site Number 840050

🇺🇸

Houston, Texas, United States

Investigational Site Number 840043

🇺🇸

Morgantown, West Virginia, United States

Investigational Site Number 643003

🇷🇺

Moscow, Russian Federation

Investigational Site Number 840011

🇺🇸

Sant Barbara, California, United States

Investigational Site Number 840019

🇺🇸

Maywood, Illinois, United States

Investigational Site Number 840037

🇺🇸

Hazard, Kentucky, United States

Investigational Site Number 840008

🇺🇸

St Louis, Missouri, United States

Investigational Site Number 840032

🇺🇸

Lubbock, Texas, United States

Investigational Site Number 032007

🇦🇷

Capital Federal, Argentina

Investigational Site Number 036002

🇦🇺

Box Hill, Australia

Investigational Site Number 032004

🇦🇷

Buenos Aires, Argentina

Investigational Site Number 040001

🇦🇹

Graz, Austria

Investigational Site Number 040002

🇦🇹

Wels, Austria

Investigational Site Number 032014

🇦🇷

Córdoba, Argentina

Investigational Site Number 112006

🇧🇾

Gomel, Belarus

Investigational Site Number 036003

🇦🇺

Box Hill, Australia

Investigational Site Number 112004

🇧🇾

Vitebsk, Belarus

Investigational Site Number 112007

🇧🇾

Vitebsk, Belarus

Investigational Site Number 076003

🇧🇷

Belo Horizonte, Brazil

Investigational Site Number 056002

🇧🇪

Genk, Belgium

Investigational Site Number 056001

🇧🇪

Gent, Belgium

Investigational Site Number 076014

🇧🇷

Caxias Do Sul, Brazil

Investigational Site Number 076006

🇧🇷

Goiania, Brazil

Investigational Site Number 076005

🇧🇷

Curitiba, Brazil

Investigational Site Number 076011

🇧🇷

Joinville, Brazil

Investigational Site Number 076015

🇧🇷

Ribeirao Preto, Brazil

Investigational Site Number 076009

🇧🇷

Porto Alegre, Brazil

Investigational Site Number 076013

🇧🇷

Sao Jose Do Rio Preto, Brazil

Investigational Site Number 100003

🇧🇬

Ruse, Bulgaria

Investigational Site Number 076004

🇧🇷

Sao Paulo, Brazil

Investigational Site Number 100004

🇧🇬

Pleven, Bulgaria

Investigational Site Number 076002

🇧🇷

Sao Paulo, Brazil

Investigational Site Number 076008

🇧🇷

Sao Paulo, Brazil

Investigational Site Number 100006

🇧🇬

Varna, Bulgaria

Investigational Site Number 100011

🇧🇬

Sofia, Bulgaria

Investigational Site Number 100008

🇧🇬

Sofia, Bulgaria

Investigational Site Number 100010

🇧🇬

Varna, Bulgaria

Investigational Site Number 124004

🇨🇦

Kitchener, Canada

Investigational Site Number 124001

🇨🇦

Edmonton, Canada

Investigational Site Number 156013

🇨🇳

Haikou, China

Investigational Site Number 152001

🇨🇱

Santiago, Chile

Investigational Site Number 124011

🇨🇦

Red Deer, Canada

Investigational Site Number 156011

🇨🇳

Baotou, China

Investigational Site Number 156012

🇨🇳

Changsha, China

Investigational Site Number 156010

🇨🇳

Changsha, China

Investigational Site Number 156006

🇨🇳

Fuzhou, China

Investigational Site Number 156001

🇨🇳

Shijiazhuang, China

Investigational Site Number 156003

🇨🇳

Guangzhou, China

Investigational Site Number 156004

🇨🇳

Xi'An, China

Investigational Site Number 203001

🇨🇿

Brno, Czech Republic

Investigational Site Number 191004

🇭🇷

Pozega, Croatia

Investigational Site Number 191001

🇭🇷

Pula, Croatia

Investigational Site Number 203011

🇨🇿

Jihlava, Czech Republic

Investigational Site Number 191002

🇭🇷

Zagreb, Croatia

Investigational Site Number 203007

🇨🇿

Brno, Czech Republic

Investigational Site Number 208002

🇩🇰

Odense C, Denmark

Investigational Site Number 203014

🇨🇿

Most, Czech Republic

Investigational Site Number 203012

🇨🇿

Pardubice, Czech Republic

Investigational Site Number 203006

🇨🇿

Praha 5, Czech Republic

Investigational Site Number 203002

🇨🇿

Praha 6, Czech Republic

Investigational Site Number 276011

🇩🇪

Bochum, Germany

Investigational Site Number 203003

🇨🇿

Ostrava, Czech Republic

Investigational Site Number 276001

🇩🇪

Stralsund, Germany

Investigational Site Number 208001

🇩🇰

København Nv, Denmark

Investigational Site Number 276012

🇩🇪

Hannover, Germany

Investigational Site Number 233002

🇪🇪

Tartu, Estonia

Investigational Site Number 276015

🇩🇪

Castrop-Rauxel, Germany

Investigational Site Number 300002

🇬🇷

Heraklion, Greece

Investigational Site Number 276016

🇩🇪

Magdeburg, Germany

Investigational Site Number 348007

🇭🇺

Debrecen, Hungary

Investigational Site Number 276014

🇩🇪

Lübeck, Germany

Investigational Site Number 348008

🇭🇺

Szeged, Hungary

Investigational Site Number 356008

🇮🇳

Bangalore, India

Investigational Site Number 356031

🇮🇳

Bhopal, India

Investigational Site Number 356018

🇮🇳

Chennai, India

Investigational Site Number 356014

🇮🇳

Chennai, India

Investigational Site Number 356021

🇮🇳

Chennai, India

Investigational Site Number 356016

🇮🇳

Chennai, India

Investigational Site Number 356022

🇮🇳

Jaipur, India

Investigational Site Number 356010

🇮🇳

Hyderabad, India

Investigational Site Number 356002

🇮🇳

Jaipur, India

Investigational Site Number 356007

🇮🇳

Kochi, India

Investigational Site Number 356032

🇮🇳

Ludhiana, India

Investigational Site Number 356003

🇮🇳

Luknow, India

Investigational Site Number 380009

🇮🇹

Aviano, Italy

Investigational Site Number 380001

🇮🇹

Genova, Italy

Investigational Site Number 356012

🇮🇳

Punjgutta, India

Investigational Site Number 356023

🇮🇳

Pune, India

Investigational Site Number 356015

🇮🇳

Pune, India

Investigational Site Number 356009

🇮🇳

New Delhi, India

Investigational Site Number 380015

🇮🇹

Genova, Italy

Investigational Site Number 380006

🇮🇹

Milano, Italy

Investigational Site Number 380004

🇮🇹

Padova, Italy

Investigational Site Number 380012

🇮🇹

Pordenone, Italy

Investigational Site Number 380013

🇮🇹

Piacenza, Italy

Investigational Site Number 380008

🇮🇹

Parma, Italy

Investigational Site Number 410001

🇰🇷

Gyeonggi-do, Korea, Republic of

Investigational Site Number 410009

🇰🇷

Incheon, Korea, Republic of

Investigational Site Number 380007

🇮🇹

Trieste, Italy

Investigational Site Number 380005

🇮🇹

Reggio Emilia, Italy

Investigational Site Number 380011

🇮🇹

San Donato Milanese, Italy

Investigational Site Number 410004

🇰🇷

Seoul, Korea, Republic of

Investigational Site Number 410006

🇰🇷

Goyang, Korea, Republic of

Investigational Site Number 410007

🇰🇷

Daegu, Korea, Republic of

Investigational Site Number 410002

🇰🇷

Seoul, Korea, Republic of

Investigational Site Number 410011

🇰🇷

Seoul, Korea, Republic of

Investigational Site Number 410010

🇰🇷

Seoul, Korea, Republic of

Investigational Site Number 410008

🇰🇷

Seoul, Korea, Republic of

Investigational Site Number 410003

🇰🇷

Suwon, Korea, Republic of

Investigational Site Number 428004

🇱🇻

Daugavpils, Latvia

Investigational Site Number 428003

🇱🇻

Riga, Latvia

Investigational Site Number 484001

🇲🇽

Guadalajara, Mexico

Investigational Site Number 440001

🇱🇹

Kaunas, Lithuania

Investigational Site Number 428002

🇱🇻

Riga, Latvia

Investigational Site Number 440003

🇱🇹

Kaunas, Lithuania

Investigational Site Number 484006

🇲🇽

Mazatlán, Mexico

Investigational Site Number 554003

🇳🇿

Christchurch, New Zealand

Investigational Site Number 554001

🇳🇿

Christchurch, New Zealand

Investigational Site Number 554002

🇳🇿

Nelson South, New Zealand

Investigational Site Number 578001

🇳🇴

Trondheim, Norway

Investigational Site Number 604001

🇵🇪

Lima, Peru

Investigational Site Number 604004

🇵🇪

Callao, Peru

Investigational Site Number 616001

🇵🇱

Bydgoszcz, Poland

Investigational Site Number 604005

🇵🇪

Lima, Peru

Investigational Site Number 616006

🇵🇱

Gdansk, Poland

Investigational Site Number 616018

🇵🇱

Krakow, Poland

Investigational Site Number 616009

🇵🇱

Lodz, Poland

Investigational Site Number 616002

🇵🇱

Lodz, Poland

Investigational Site Number 616015

🇵🇱

Sosnowiec, Poland

Investigational Site Number 616012

🇵🇱

Poznan, Poland

Investigational Site Number 616004

🇵🇱

Warszawa, Poland

Investigational Site Number 616013

🇵🇱

Szczecin, Poland

Investigational Site Number 616007

🇵🇱

Wroclaw, Poland

Investigational Site Number 616016

🇵🇱

Wroclaw, Poland

Investigational Site Number 643001

🇷🇺

Moscow, Russian Federation

Investigational Site Number 643002

🇷🇺

Moscow, Russian Federation

Investigational Site Number 643017

🇷🇺

St-Petersburg, Russian Federation

Investigational Site Number 752001

🇸🇪

Stockholm, Sweden

Investigational Site Number 032012

🇦🇷

Rosario, Argentina

Investigational Site Number 076012

🇧🇷

Curitiba, Brazil

Investigational Site Number 036008

🇦🇺

Redcliffe, Australia

Investigational Site Number 276004

🇩🇪

Homburg, Germany

Investigational Site Number 032002

🇦🇷

Buenos Aires, Argentina

Investigational Site Number 032005

🇦🇷

Santa Fe, Argentina

Investigational Site Number 840020

🇺🇸

Teaneck, New Jersey, United States

Investigational Site Number 036001

🇦🇺

Kogarah, Australia

Investigational Site Number 276002

🇩🇪

Heidelberg, Germany

Investigational Site Number 076010

🇧🇷

Belo Horizonte, Brazil

Investigational Site Number 276013

🇩🇪

München, Germany

Investigational Site Number 348009

🇭🇺

Kistarcsa, Hungary

Investigational Site Number 112005

🇧🇾

Minsk, Belarus

Investigational Site Number 203009

🇨🇿

Kromeriz, Czech Republic

Investigational Site Number 203004

🇨🇿

Liberec, Czech Republic

Investigational Site Number 348004

🇭🇺

Szekesfehervar, Hungary

Investigational Site Number 356011

🇮🇳

Bangalore, India

Investigational Site Number 604002

🇵🇪

Lima, Peru

Investigational Site Number 112003

🇧🇾

Minsk, Belarus

Investigational Site Number 112002

🇧🇾

Minsk, Belarus

Investigational Site Number 100005

🇧🇬

Sofia, Bulgaria

Investigational Site Number 112008

🇧🇾

Minsk, Belarus

Investigational Site Number 203016

🇨🇿

Ricany, Czech Republic

Investigational Site Number 203010

🇨🇿

Usti Nad Labem, Czech Republic

Investigational Site Number 356033

🇮🇳

Andhra Pradesh, India

Investigational Site Number 100009

🇧🇬

Sofia, Bulgaria

Investigational Site Number 233001

🇪🇪

Tartu, Estonia

Investigational Site Number 356005

🇮🇳

Ahmedabad, India

Investigational Site Number 356013

🇮🇳

Cochin, India

Investigational Site Number 356028

🇮🇳

Hyderabad, India

Investigational Site Number 356026

🇮🇳

Lucknow, India

Investigational Site Number 440002

🇱🇹

Vilnius, Lithuania

Investigational Site Number 604003

🇵🇪

Callao, Peru

Investigational Site Number 616020

🇵🇱

Krakow, Poland

Investigational Site Number 804005

🇺🇦

Kyiv, Ukraine

Investigational Site Number 804008

🇺🇦

Odessa, Ukraine

Investigational Site Number 203008

🇨🇿

Praha 4, Czech Republic

Investigational Site Number 348003

🇭🇺

Szolnok, Hungary

Investigational Site Number 356019

🇮🇳

Banglore, India

Investigational Site Number 356025

🇮🇳

Gujarat, India

Investigational Site Number 356030

🇮🇳

Nagpur, India

Investigational Site Number 616005

🇵🇱

Krakow, Poland

Investigational Site Number 616014

🇵🇱

Warszawa, Poland

Investigational Site Number 642004

🇷🇴

Oradea, Romania

Investigational Site Number 643011

🇷🇺

St-Petersburg, Russian Federation

Investigational Site Number 643014

🇷🇺

Yaroslavl, Russian Federation

Investigational Site Number 804002

🇺🇦

Kyiv, Ukraine

Investigational Site Number 840015

🇺🇸

Orlando, Florida, United States

Investigational Site Number 643025

🇷🇺

Moscow, Russian Federation

Investigational Site Number 156005

🇨🇳

Nanjing, China

© Copyright 2025. All Rights Reserved by MedPath